Neoadjuvant chemoradiotherapy (NCRT) plus surgery significantly improves survival vs surgery alone in locally advanced esophageal squamous cell carcinoma (ESCC), with acceptable and manageable adverse events, according to a new study.
http://www.cancernetwork.com/head-neck-cancer/controversy-over-ncrt-plus-surgery-warranted-esophageal-squamous-cell-carcinoma
Is Controversy Over NCRT Plus Surgery Warranted in Esophageal Squamous Cell Carcinoma?